Physician profile
Timothy J Kruser
NPI 1053576926
$235,440.81
in general payments reported to CMS, 2019-2025
6 companies · $23K in 2025
The $23K reported for 2025 was more than what 98% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99K · 2020: $18K · 2021: $32K · 2022: $24K · 2023: $15K · 2024: $25K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Consulting Fee: $17K · Travel and Lodging: $2,578 · Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,470.00 |
| Consulting Fee | $16,527.50 |
| Travel and Lodging | $2,577.67 |
| Food and Beverage | $935.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $233,035.67 | 2019-2025 | Imfinzi, Tagrisso |
| Pfizer INC. | $1,600.00 | 2022 | |
| Raysearch Laboratories Ab (Publ) | $485.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $160.97 | 2022-2023 | |
| Boston Scientific Corporation | $153.68 | 2019 | |
| Fortovia Therapeutics, INC. | $5.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kruser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.